Perspectives of Pulmonologists on the 2009-2010 H1N1 Vaccination Effort
- PMID: 22272372
- PMCID: PMC3261484
- DOI: 10.1155/2012/306207
Perspectives of Pulmonologists on the 2009-2010 H1N1 Vaccination Effort
Abstract
Persons with high-risk conditions such as asthma were a target group for H1N1 vaccine recommendations. We conducted a mailed survey of a national sample of pulmonologists to understand their participation in the 2009-2010 H1N1 vaccine campaign. The response rate was 59%. The majority of pulmonologists strongly recommended H1N1 vaccine for children (73%) and adults aged 25-64 years (51%). Only 60% of respondents administered H1N1 vaccine in their practice compared to 87% who offered seasonal influenza vaccine. Other than vaccine supply, respondents who provided H1N1 vaccine reported few logistical problems. Two-thirds of respondents would be very likely to vaccinate during a future influenza pandemic; this rate was higher among those who provided H1N1 vaccine and/or seasonal flu vaccine. In total, the H1N1 vaccine-related experiences of pulmonologists seemed to be positive. However, additional efforts are needed to increase participation in future pandemic vaccination campaigns.
Similar articles
-
Perspectives of allergists/immunologists on the 2009-2010 H1N1 vaccination effort.J Asthma. 2012 Mar;49(2):184-9. doi: 10.3109/02770903.2011.654301. Epub 2012 Feb 2. J Asthma. 2012. PMID: 22300193
-
Involvement of endocrinologists in the 2009 to 2010 H1N1 vaccination effort.Endocr Pract. 2012 Jul-Aug;18(4):464-71. doi: 10.4158/EP11358.OR. Endocr Pract. 2012. PMID: 22805112
-
Obstetricians and the 2009-2010 H1N1 vaccination effort: implications for future pandemics.Matern Child Health J. 2013 Sep;17(7):1185-90. doi: 10.1007/s10995-012-1104-x. Matern Child Health J. 2013. PMID: 22911451 Free PMC article.
-
Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.MMWR Recomm Rep. 2009 Aug 28;58(RR-10):1-8. MMWR Recomm Rep. 2009. PMID: 19713882
-
Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.Drugs R D. 2003;4(5):312-9. doi: 10.2165/00126839-200304050-00007. Drugs R D. 2003. PMID: 12952502 Review.
References
-
- Chan M. World now at the start of 2009 influenza pandemic. Statement to the press by WHO Director-General Dr. Margaret Chan, June 2009, http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6....
-
- US Food and Drug Administration. FDA Approves Vaccines for 2009 H1N1 Influenza Virus. Press release, September 2009, http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm182399.htm.
-
- Centers for Disease Control and Prevention. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. Morbidity and Mortality Weekly Report. 2009 ;58(RR-10):1–8. - PubMed
-
- Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. New England Journal of Medicine. 2009;361(20):1935–1944. - PubMed
-
- Centers for Disease Control and Prevention. Hospitalized patients with novel influenza A (H1N1) virus infection—California, April-May, 2009. Morbidity and Mortality Weekly Report. 2009;58(19):536–541. - PubMed
LinkOut - more resources
Full Text Sources